期刊文献+

Cox模型预测云南省美沙酮维持治疗早期脱失的风险因素分析 被引量:1

The predictors of early dropout in methadone maintenance treatment in Yunnan province
原文传递
导出
摘要 目的:云南省美沙酮维持治疗早期脱失相关因素分析。方法:用队列研究的方法观察2009年3月1日至8月31日期间,218例第一次入组美沙酮门诊的调查对象,并随访到2010年2月28日。美沙酮剂量的记录来自于门诊的数据库。利用Cox回归模型进行数据分析。结果:在第1、2个阶段美沙酮剂量和脱失之间没有关系,而在3个月后高剂量组(>60mg)脱失的可能性较小。脱失还与汉族(HR=1.86,95%CI:1.65-3.26)、到达门诊时间超过30分钟(HR=1.63,95%CI:1.07-2.49)及与药物滥用者住在一起(HR=2.71,95%CI:1.55-4.74)有关。结论:病人早期脱失和民族、门诊可及性、和药物滥用者居住在一起以及美沙酮的剂量有关。推荐使用更高剂量的美沙酮可能对美沙酮维持治疗更有用。 Objective:To identify the predictors of early dropout of patients in methadone maintenance treatment (MMT) clinics in Yunnan province, China. Methods: A cohort study was conducted on 218 patients starting treatment in 5 MMT clinics between March 1, 2009 and August 31, with follow up to February 28, 2010. Attendance at clinic and daily dose were abstracted from the clinic records. Cox regression model was performed to identify factors predicting dropout in the MMT program. Results:There was no relationship between dose and probability of dropout in periods 1 and 2. However, after 3 months higher average daily dose ( 〉 60 mg) was as- sociated with lower probability of dropout. Dropout was more likely among the Han ethnic group (HR = 1.86, 95% CI: 1.65-3.26), in those who had to spend over 30 minutes to visit the clinic (HR = 1.63, 95% CI: 1.07-2.49) , and in those living with other drug users (HR = 2. 71, 95% CI: 1.55-4. 74 ). Conclusion:Patients" early dropout was related to ethnicity, clinic accessibility, living with drug users and methadone dose. A higher methadone dose as appropriate for maintenance treatment is recommended.
出处 《中国药物滥用防治杂志》 CAS 2011年第6期320-324,共5页 Chinese Journal of Drug Abuse Prevention and Treatment
关键词 风险因素 美沙酮剂量 美沙酮维持治疗 脱失 Predictors, Methadone dose, Methadone maintenance treatment, Dropout
  • 相关文献

参考文献1

二级参考文献14

  • 1陈显煌,姜正清,阮玉华,刘刚,秦光明,张亚峰,刘石柱,何益新,周枫,尹潞,张莉,陈康林,邵一鸣.吸毒人群队列本底的人口学和HIV高危行为因素与保持率关系的研究[J].预防医学情报杂志,2004,20(6):616-619. 被引量:10
  • 2姜正清,胡薇,张莉,冯宗亮,刘石柱,何益新,周枫,秦光明,尹潞,陈康林,邢辉,阮玉华,邵一鸣.静脉吸毒人群HIV阳转率与队列保持影响因素[J].中国公共卫生,2005,21(11):1289-1291. 被引量:7
  • 3Simpson DD, Joe GW, Rowan-Szal GA, et al. Drug abuse treatment process components that improve retention. J Subst Abuse Treat,1997,14(6) :565-572.
  • 4Brady TM,Salvueei S, Sverdlov LS, et al. Methadone dosage and retention: an examination of the 60 mg/day threshold. J Addict Dis,2005,24(3) :23-47.
  • 5Brown BS, Joe GW, Thompson P. Minority group status and treatment retention. Int J Addict, 1985,20(2) : 319-335.
  • 6Torrens M, Castillo C, Perez-Sola V. Retention in a low-thresh-old methadone maintenance treatment program. Drug alcohol depend,1996,41(1) :55-59.
  • 7Steer RA. Psychosocial correlates of retention in methadone maintenance. Int Addict, 1980,15 (7): 1003-1009.
  • 8Newman RG,Tytun A, Bashkow S. Retention of patients in the New York City methadone maintenance treatment program. Int J Addict, 1976,11(5) :905-931.
  • 9Johnson RE, Jaffe JH, Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA, 1992,267(20) : 2750-2755.
  • 10Magura S, Nwakeze PC, Demsky SY. Pre and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 1998,93 ( 1 ) :51-60.

共引文献24

同被引文献16

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部